Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Co-treatment with both 50 μM BRL 49653 and 10 μM GW-9662 results in statistically lower viable cell numbers after 7 days when compared to treatment with either 50 μM BRL 49653 (P=0
6 nM in MV4-11 cells
Currently GDC-0349 is in Phase I clinical trials to evaluate the safety and tolerability in patients with locally advanced or metastatic solid tumors or Non-Hodgkin's lymphoma
The oral bioavailability of Trimethobenzamide is 60% to 100%
Chemical Name: 6-{[(4-chlorophenyl)methyl]sulfanyl}-3-[2-(3
Quassin (hemihydrate) Co-treatment with both 50 μMQuassin (Nigakilactone D) is a bioactive triterpenoid from stem bark extract of Quassia amara. Quassin inhibits P. falciparum with an IC50 of 0. 15 M. Quassin possesses reversible antifertility, anti estrogenic and anti plasmodial activity. Product information CAS Number: 76 78 8 Molecular Weight: 388. 45 Formula: C22H28O6 Chemical Name: (3aR, 3a1S, 6aR, 7aS, 8S, 11aS, 11bS) 2, 10 dimethoxy 3, 3a1, 8, 11a tetramethyl 3a, 4, 6a, 7, 7a, 8, 11a, 11b
US$ 15.99
US$ 69.99
US$ 149.50
US$ 349.50
US$ 51.00
US$ 600.00